Ir para o conteúdo principal

United StatesÚltimas notícias

Bloomberg

Anthropic Talks With Pentagon Stall Over Claude AI Guardrails

Anthropic PBC's talks about extending a contract with the Pentagon are being held up over additional protections the artificial intelligence company wants to put on its Claude tool, a person familiar with the matter said. Anthropic wants to put guardrails in place to stop Claude from being used for mass surveillance of Americans or to develop weapons that can be deployed without a human involved, the person said, asking not to be identified because the negotiations are private. The Pentagon wants to be able to use Claude as long as its deployment doesn't break the law. Bloomberg News Tech and National Security Reporter Katrina Manson joins Bloomberg Businessweek Daily to discuss. She speaks with Carol Massar and Tim Stenovec.

Leia mais: Anthropic Talks With Pentagon Stall Over Claude AI Guardrails
Grafa
Industrials

Builders FirstSource profits tumble as housing market softness weighs on margins

Builders FirstSource (NYSE:BLDR) reported a significant decline in fourth-quarter profitability, as the nation's largest supplier of structural building products grappled with a "below-normal" environment for new residential housing starts and persistent commodity deflation.

Leia mais: Builders FirstSource profits tumble as housing market softness weighs on margins
Grafa
Health

Teva and Sanofi’s duvakitug clears key long-term hurdle in IBD race

Teva Pharmaceutical Industries (NYSE:TEVA) and Sanofi (NASDAQ:SNY) announced a major clinical victory on Tuesday, revealing that their investigational antibody, duvakitug (formerly TEV-574), successfully maintained disease control in patients with inflammatory bowel disease (IBD) for nearly a full year.

Leia mais: Teva and Sanofi’s duvakitug clears key long-term hurdle in IBD race